Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - OTHER LONG-TERM ASSETS
Other Long-term Assets HALO - Halozyme Therapeutics, Inc.
80.6 M
LAST VALUE
75.05%
2 YEAR CAGR
48.71%
5 YEAR CAGR
47.05%
10 YEAR CAGR